Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients

Mar 4, 2013 · 2m 10s
Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients
Description
Dr. Greg Riely from Memorial Sloan-Kettering notes how he feels molecular marker results for patients with earlier stage lung cancer can potentially be valuable.
Information
Author cancerGRACE
Organization cancerGRACE
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search